ArticleJournal of diabetes investigation2025
Canagliflozin protects cardiovascular function in type 2 diabetic coronary artery disease by regulating natriuretic peptide B.
Jiarui Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.